Susan Dexter's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 8,000 Common Stock done . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Hol... | Susan Dexter | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 8,000 | 9,643 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | Dexter Susan | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 1,452 | 1,643 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | Susan Dexter | Chief Technical Officer | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 14 Jun 2023 | 10,000 | 33,667 | - | 0.7 | 7,000 | Common Stock |
| Sonnet BioTherapeutics Hol... | Susan Dexter | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2023 | 14,627 | 23,667 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | Susan Dexter | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2023 | 14,627 | 9,040 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | Susan Dexter | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 14,627 | 141,199 | - | - | Common Stock | |
| Sonnet BioTherapeutics Hol... | Susan Dexter | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.51 per share. | 25 May 2021 | 10,145 | 63,468 | - | 1.5 | 15,319 | Common Stock |